title: Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension.
authors.affiliation: Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana 70121, USA.
authors.forename: J
authors.initials: J
authors.lastname: Jordan
authors.forename: F H
authors.initials: FH
authors.lastname: Messerli
authors.forename: C J
authors.initials: CJ
authors.lastname: Lavie
authors.forename: F C
authors.initials: FC
authors.lastname: Aepfelbacher
authors.forename: F
authors.initials: F
authors.lastname: Soria
mesh_terms: D015057:1-Naphthylamine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage*; D020280:Sertraline; D016037:Single-Blind Method; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline